Locations
United States · Seattle, WA, USA · University of Washington, Seattle, WA, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Other
founded in
2009
RareCyte is a life sciences company specializing in advanced Precision Biology platforms, including instruments, reagents, software, and services for Spatial Biology and Liquid Biopsy solutions. Their innovative technologies, such as the Orion Spatial Biology platform and Cyte Finder instruments, empower researchers and clinicians to detect and analyze rare cells, including circulating tumor cells (CTCs), with high sensitivity and accuracy. RareCyte's commitment to enhancing therapeutic development and diagnostics positions them as a leader in the rapidly growing fields of cancer research and precision medicine, supported by significant collaborations and funding.
Something looks off?